Neuromodulation Market Report 2024 by Delvens offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance, the global Neuromodulation Market size is projected to reach a CAGR of 11.2% from 2023-2030.
Get Free Sample Report: https://www.delvens.com/get-free-sample/neuromodulation-market
The prominent players in Neuromodulation Market are
· Abbott
· Aleva
· Neurotherapeutics SA.
· Boston Scientific Corporation
· LivaNova
· Medtronic
· MicroTransponder
· Neuronetics
· NeuroPace Inc.
· NeuroSigma
· Nevro Corporation and More
Neurological disorders are defined as disorders that affect the brain as well as the nerves found throughout the human body and the spinal cord. Acute spinal cord injury, Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), ataxia, bell's palsy, brain tumors, cerebral aneurysm, epilepsy, and seizures are some of the common neurological disorders.
The biochemical, structural, or electrical abnormalities in the brain, spinal cord, or other nerves result in a wide range of symptoms, such as memory loss, impaired mental ability, lack of coordination, and persistent or sudden onset of a headache. Neuromodulation technology utilizes devices that bring about a change in the nervous system either by stimulation or by modulating brain activity. These are used when the traditional treatments have failed to evoke the desired response.
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/neuromodulation-market
Regional Analysis
North America to Dominate the Market
· North America garnered the major share in the neuromodulation market in 2021 and is expected to dominate the global market during the forecast period.
· The growth is due to the rise in the prevalence of neurological diseases, the presence of key players in the development of neuromodulation devices, and the well-established infrastructure in the region.
Recent Developments
In February 2022, Medtronic (Ireland) received FDA approval for its InterStim X System, a next-generation personalized sacral nerve stimulation therapy for bladder and bowel control.
In June 2021, NeuroSigma (US) and KT Corporation (South Korea) signed a memorandum of understanding for a strategic partnership to develop and commercialize, inside and outside of Korea, electronic therapies treating neurological and neuropsychological disorders, including ADHD, depression, and epilepsy.
Neuromodulation Market is segmented into various segments such as technology, application, biomaterial, and region:
On the basis of technology
· Internal Neuromodulation
· External Neuromodulation
On the basis of application
· Chronic Pain
· Urinary And Fecal Incontinence
· Migraine
· Failed Back Syndrome
· Parkinson Disease
· Epilepsy
· Tremor
· Depression
· Other Applications
On the basis of biomaterial
· Metallic Biomaterials
· Polymeric Biomaterials
· Ceramic Biomaterials
On the basis of region
· Asia Pacific
· North America
· Europe
· South America
· Middle East & Africa
Access Full Report: https://www.delvens.com/report/neuromodulation-market
In addition to the market data for Neuromodulation Market, Delvens offers a client-centric report customized according to the company’s specific demand and requirement.
Access More Reports:
Network Test Lab Automation Market
Nerve Repair & Regeneration Market
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
Unit No. 01, 3rd Floor, Plot No. 56, Block B
Sector 2 Noida, Near Noida Sector 15 Metro Station 201301, IN
+44 20 3290 6466
+0120- 4903958
